EUR 1.47
(8.09%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 255.82 Thousand EUR | -65.97% |
2022 | 751.8 Thousand EUR | 2541.99% |
2021 | 28.45 Thousand EUR | -60.9% |
2020 | 72.77 Thousand EUR | 1432.04% |
2019 | 4750.00 EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 181.27 Thousand EUR | 0.0% |
2023 Q2 | -532.29 Thousand EUR | -1163.61% |
2023 FY | -1.01 Million EUR | -234.41% |
2023 Q3 | 77.86 Thousand EUR | 114.63% |
2023 Q1 | 50.04 Thousand EUR | 114.59% |
2023 Q4 | 77.86 Thousand EUR | 0.0% |
2022 Q3 | 150.35 Thousand EUR | 149.03% |
2022 Q2 | -306.65 Thousand EUR | -562.02% |
2022 Q1 | 66.37 Thousand EUR | -41.35% |
2022 FY | 751.8 Thousand EUR | 2541.99% |
2022 Q4 | -343.02 Thousand EUR | -328.15% |
2021 FY | 28.45 Thousand EUR | -60.9% |
2021 Q1 | 66.25 Thousand EUR | -21.1% |
2021 Q4 | 113.16 Thousand EUR | -33.35% |
2021 Q3 | 169.77 Thousand EUR | 68.49% |
2021 Q2 | 100.76 Thousand EUR | 52.08% |
2020 Q1 | 154.51 Thousand EUR | 0.0% |
2020 Q4 | 83.98 Thousand EUR | 0.0% |
2020 FY | 72.77 Thousand EUR | 1432.04% |
2020 Q3 | 83.98 Thousand EUR | -45.65% |
2020 Q2 | 154.51 Thousand EUR | 0.0% |
2019 FY | 4750.00 EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Affluent Medical SA | -1.2 Million EUR | 121.319% |
Bluelinea Société Anonyme | -3.84 Million EUR | 106.649% |
Carmat SA | -30.97 Million EUR | 100.826% |
Diagnostic Medical Systems S.A. | 15.84 Million EUR | 98.385% |
Euromedis Groupe | 3.57 Million EUR | 92.837% |
Eurobio Scientific Société anonyme | 53.96 Million EUR | 99.526% |
Implanet S.A. | 3.13 Million EUR | 91.832% |
Median Technologies SA | -2.55 Million EUR | 110.028% |
SpineGuard SA | 3.37 Million EUR | 92.429% |
Theraclion SA | -1.08 Million EUR | 123.679% |
Euroapi S.A. | 164.6 Million EUR | 99.845% |
Guerbet SA | 197.14 Million EUR | 99.87% |
Ion Beam Applications SA | 134.44 Million EUR | 99.81% |
Koninklijke Philips N.V. | 7.44 Billion EUR | 99.997% |
Sequana Medical NV | 548.04 Thousand EUR | 53.32% |